PQA

RESEARCH COORDINATING COUNCIL



This workgroup will be comprised of 12-15 members and will include researchers, community pharmacists, and personnel from drug plans and potential data aggregators. The group will provide ongoing input to research initiatives being undertaken by PQA, including the 2010 Phase II Demonstration Projects.

Co-Chairs:

Eleanor M. Perfetto, PhD, MS, Senior Director, Reimbursement & Regulatory Affairs
Federal Government Relations
Pfizer Inc

Kristina Yu-Isenberg, PhD, MPH, RPh, Director, Regional Outcomes Research
US Medical Affairs - Southeast Operating Unit

Novartis Pharmaceuticals Corporation